20,274 Shares in Xylem Inc. $XYL Purchased by Caxton Associates LLP

Caxton Associates LLP acquired a new position in Xylem Inc. (NYSE:XYL) in the first quarter, Holdings Channel reports. The fund acquired 20,274 shares of the industrial products company’s stock, valued at approximately $2,423,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in XYL. Wexford Capital LP bought a new position in shares of Xylem during the 3rd quarter worth approximately $27,000. Commonwealth Retirement Investments LLC bought a new position in shares of Xylem in the fourth quarter valued at approximately $27,000. Entrust Financial LLC purchased a new stake in shares of Xylem during the fourth quarter valued at approximately $45,000. FWL Investment Management LLC bought a new stake in Xylem during the second quarter worth $43,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Xylem in the fourth quarter worth $45,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

Shares of Xylem stock opened at $119.66 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a fifty day moving average of $114.04 and a 200-day moving average of $122.82. The stock has a market capitalization of $28.44 billion, a price-to-earnings ratio of 29.77, a price-to-earnings-growth ratio of 1.66 and a beta of 1.03.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.11 billion. During the same quarter last year, the company earned $1.03 EPS. The firm’s revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Equities research analysts expect that Xylem Inc. will post 5.52 EPS for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s payout ratio is 42.79%.

Insider Activity

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This trade represents a 54.22% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jerome A. Peribere purchased 1,210 shares of the company’s stock in a transaction on Monday, May 4th. The shares were purchased at an average cost of $116.61 per share, with a total value of $141,098.10. Following the transaction, the director directly owned 27,209 shares in the company, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on XYL shares. Oppenheimer decreased their target price on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. Citigroup cut their price target on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Barclays decreased their price objective on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. UBS Group raised their target price on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Finally, Stifel Nicolaus lowered their price target on shares of Xylem from $159.00 to $157.00 and set a “buy” rating on the stock in a research report on Monday. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $153.15.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.